IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 418 filers reported holding IMMUNOMEDICS INC in Q3 2020. The put-call ratio across all filers is 0.82 and the average weighting 1.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $63,772,000 | +91.8% | 749,995 | -20.1% | 0.08% | +85.7% |
Q2 2020 | $33,248,000 | +220.1% | 938,141 | +21.8% | 0.04% | +162.5% |
Q1 2020 | $10,386,000 | -36.3% | 770,491 | +0.0% | 0.02% | -15.8% |
Q4 2019 | $16,297,000 | +93.1% | 770,191 | +21.0% | 0.02% | +72.7% |
Q3 2019 | $8,439,000 | -3.3% | 636,409 | +1.2% | 0.01% | 0.0% |
Q2 2019 | $8,723,000 | -8.1% | 628,917 | +27.3% | 0.01% | -8.3% |
Q1 2019 | $9,491,000 | +261.4% | 494,044 | +168.4% | 0.01% | +200.0% |
Q4 2018 | $2,626,000 | -32.2% | 184,056 | -1.0% | 0.00% | -20.0% |
Q3 2018 | $3,871,000 | -13.4% | 185,827 | -1.6% | 0.01% | -16.7% |
Q2 2018 | $4,468,000 | +121.6% | 188,773 | +36.8% | 0.01% | +100.0% |
Q1 2018 | $2,016,000 | -9.6% | 137,973 | 0.0% | 0.00% | 0.0% |
Q4 2017 | $2,230,000 | +22.4% | 137,973 | +5.9% | 0.00% | +50.0% |
Q3 2017 | $1,822,000 | +98.5% | 130,325 | +25.3% | 0.00% | +100.0% |
Q2 2017 | $918,000 | +36.4% | 104,000 | -0.0% | 0.00% | 0.0% |
Q1 2017 | $673,000 | +108.4% | 104,001 | +18.3% | 0.00% | – |
Q4 2016 | $323,000 | +12.9% | 87,900 | 0.0% | 0.00% | – |
Q3 2016 | $286,000 | +40.2% | 87,900 | 0.0% | 0.00% | – |
Q2 2016 | $204,000 | -7.3% | 87,900 | 0.0% | 0.00% | – |
Q1 2016 | $220,000 | -18.5% | 87,900 | 0.0% | 0.00% | – |
Q4 2015 | $270,000 | +78.8% | 87,900 | 0.0% | 0.00% | – |
Q3 2015 | $151,000 | -61.0% | 87,900 | -7.9% | 0.00% | -100.0% |
Q2 2015 | $387,000 | – | 95,392 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|